KTE-X19 in Relapsed or Refractory Mantle-Cell Lymphoma, a "Real-Life" Study From the DESCAR-T Registry and LYSA Group

被引：0
|
作者：
不详
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2022年 / 20卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：15 / 16
页数：2
相关论文
共 50 条
  • [21] Product Characteristics and Pharmacological Profile of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma in the Phase II Registrational ZUMA-2 Trial
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (08) : 4 - 6
  • [22] Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma treated with anti-CD19 CAR-T cells: CARTHYM, a study from the French national DESCAR-T registry
    Galtier, Jean
    Mesguich, Charles
    Sesques, Pierre
    Dupont, Vivien
    Bachy, Emmanuel
    Di Blasi, Roberta
    Thieblemont, Catherine
    Gastinne, Thomas
    Cartron, Guillaume
    Brisou, Gabriel
    Gros, Francois-Xavier
    Decroocq, Justine
    Morschhauser, Franck
    Rubio, Marie-Therese
    La Rochelle, Laurianne Drieu
    Le Bras, Fabien
    Carras, Sylvain
    Chauchet, Adrien
    Bay, Jacques-Olivier
    Joris, Magalie
    Loschi, Mickael
    Tanguy-Schmidt, Aline
    Marquet, Alexandra
    Camus, Vincent
    Le Gouill, Steven
    Houot, Roch
    Bouabdallah, Krimo
    HEMASPHERE, 2025, 9 (02):
  • [23] Pharmacological profile and clinical outcomes of KTE-X19 by prior bruton tyrosine kinase inhibitor exposure or mantle cell lymphoma morphology in patients with relapsed/refractory mantle cell lymphoma in the ZUMA-2 trial
    Wang, Michael
    Rossi, John M.
    Munoz, Javier
    Goy, Andre
    Locke, Frederick L.
    Reagan, Patrick M.
    Jacobson, Caron A.
    Hill, Brian T.
    Holmes, Houston
    Jaglowski, Samantha
    Peng, Weimin
    Zheng, Lianqing
    Fang, Xiang
    Xue, Allen
    Kloos, Ioana
    Bot, Adrian
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 43 - 44
  • [24] Efficacy and Tolerance of Brexucabtagene Autoleucel in Adults with Relapsed/Refractory B- Cell Precursor Acute Lymphoblastic Leukemia : A Graall Study from the Descar-T Registry
    Rabian, Florence
    Beauvais, David
    Marchand, Tony
    Furst, Sabine
    Huynh, Anne
    Brissot, Eolia
    Maury, Sebastien
    Gabellier, Ludovic
    Chevallier, Patrice
    Loschi, Michael
    Quoc, Stephanie Nguyen
    Balsat, Marie
    Lafon, Ingrid
    Fayard, Amandine
    Camus, Vincent
    Simand, Celestine
    Moya, Niels
    Castilla-Llorente, Cristina
    Joris, Magalie
    Berceanu, Ana
    Thiebaut, Anne
    Lheritier, Veronique
    Gehlkopf, Eve
    Roth-Guepin, Gabrielle
    Leguay, Thibaut
    Boissel, Nicolas
    BLOOD, 2023, 142
  • [25] Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study
    Wang, Michael
    Munoz, Javier
    Goy, Andre
    Locke, Frederick L.
    Jacobson, Caron A.
    Hill, Brian T.
    Timmerman, John M.
    Holmes, Houston
    Jaglowski, Samantha
    Flinn, Ian W.
    McSweeney, Peter A.
    Miklos, David B.
    Pagel, John M.
    Kersten, Marie Jose
    Bouabdallah, Krimo
    Khanal, Rashmi
    Topp, Max S.
    Houot, Roch
    Beitinjaneh, Amer
    Peng, Weimin
    Fang, Xiang
    Shen, Rhine R.
    Siddiqi, Rubina
    Kloos, Ioana
    Reagan, Patrick M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (03) : 555 - +
  • [26] Outcome of Relapsed/Refractory Aggressive B-Cell Lymphoma Patients Relapsing after Anti-CD19 CAR T-Cells and Enrolled in the Descar-T French National Registry
    Di Blasi, Roberta
    Le Gouill, Steven
    Bachy, Emmanuel
    Cartron, Guillaume
    Beauvais, David
    Le Bras, Fabien
    Gros, Francois Xavier
    Choquet, Sylvain
    Bories, Pierre
    Feugier, Pierre
    Casasnovas, Rene-Olivier
    Bay, Jacques-Olivier
    Mohty, Mohamad
    Joris, Magalie
    Gastinne, Thomas
    Sesques, Pierre
    Tudesq, Jean Jacques
    Vercellino, Laetitia
    Morschhauser, Franck
    Gat, Elodie
    Broussais, Florence
    Houot, Roch
    Thieblemont, Catherine
    BLOOD, 2021, 138
  • [27] KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients with Relapsed/refractory (R/R) Mantle Cell Lymphoma (MCL): Results from Phase 2 of ZUMA-2
    Wang, Michael
    Munoz, Javier
    Goy, Andre
    Locke, Frederick
    Jacobson, Caron
    Hill, Brian
    Timmerman, John
    Holmes, Houston
    Jaglowski, Samantha
    Flinn, Ian
    McSweeney, Peter
    Miklos, David
    Pagel, John
    Kersten, Marie Jose
    Peng, Weimin
    Zheng, Lianqing
    Rossi, John
    Jain, Rajul
    Rao, Arati
    Reagan, Patrick
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 41 - 43
  • [28] CAR T-Cell Therapy Remain Effective in Patients with Relapse/Refractory B-Cell Non-Hodgkin Lymphoma after Bispecific Antibodies Exposure: Results of a Lysa Study Based on the Descar-T Registry
    Crochet, Gilles
    Audrey, Couturier
    Bachy, Emmanuel
    Gastinne, Thomas
    Cartron, Guillaume
    Fradon, Tom
    Gounot, Romain
    Castilla-LLorente, Cristina
    Sarkozy, Clementine
    Camus, Vincent
    Guidez, Stephanie
    Chauchet, Adrien
    Deconinck, Eric
    Bouabdallah, Krimo
    Morschhauser, Franck
    Houot, Roch
    BLOOD, 2022, 140 : 4639 - 4641
  • [29] KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients (Pts) with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL): Results of the Phase 2 ZUMA-2 Study
    Wang, Michael
    Munoz, Javier
    Goy, Andre
    Locke, Frederick L.
    Jacobson, Caron A.
    Hill, Brian T.
    Timmerman, John M.
    Holmes, Houston
    Jaglowski, Samantha
    Flinn, Ian W.
    McSweeney, Peter A.
    Miklos, David B.
    Pagel, John M.
    Kersten, Marie Jose
    Peng, Weimin
    Zheng, Lianqing
    Rossi, John M.
    Jain, Rajul K.
    Rao, Arati V.
    Reagan, Patrick M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S1 - S1
  • [30] KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients (Pts) With Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results of the Phase 2 ZUMA-2 Study
    Wang, Michael L.
    Munoz, Javier
    Goy, Andre
    Locke, Frederick L.
    Jacobson, Caron A.
    Hill, Brian T.
    Timmerman, John M.
    Holmes, Houston
    Jaglowski, Samantha
    Flinn, Ian W.
    McSweeney, Peter A.
    Miklos, David B.
    Pagel, John M.
    Kersten, Marie Jose
    Peng, Weimin
    Zheng, Lianqing
    Rossi, John M.
    Jain, Rajul K.
    Rao, Arati V.
    Reagan, Patrick M.
    BLOOD, 2019, 134
12345